Long-term Outcomes of Toddlers With Autism Spectrum Disorders Exposed to Short-term Intervention

Pediatrics (Impact Factor: 5.47). 11/2012; 130(Supplement):S186-S190. DOI: 10.1542/peds.2012-0900Q


To examine long-term outcomes of toddlers with autism spectrum disorder (ASD) who received a 6-month early intervention at age 2.

Forty-eight toddlers diagnosed with an ASD received a 6-month evidence-based intervention. Cognitive (IQ) and communication ability, as well as severity of autism symptoms, were assessed by using standardized measures at preintervention (Time 1 [T1]; mean [M] age = 27 months), postintervention (T2; M age = 35 months), short-term follow-up (T3; M age = 41 months), and long-term follow-up (T4; M age = 72 months).

From pre- to postintervention, significant gains in IQ and Vineland Communication domain standard scores as well as a reduction in ASD severity were achieved (all P < .01). Between T2 and T3, the 6-month period immediately after completion of the intervention, IQ and Communication scores stabilized and ASD severity increased significantly (P < .05). During the long-term follow-up period (T3-T4), IQ and Communication scores significantly increased again, but ASD severity increased significantly as well (all P < .05). For overall trajectory (T1-T4), robust gains were observed for both IQ and communication; ASD severity did not change.

Findings highlight the potential for positive long-term outcomes in toddlers with ASD. Additional research is needed to understand the relation between early exposure to uninterrupted intervention and developmental gains, and whether initial reduction in ASD symptom severity can be sustained through targeted intervention.

1 Read
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Food and Drug Administration (FDA) has approved two mechanism-based treatments for tuberous sclerosis complex (TSC)-everolimus and vigabatrin. However, these treatments have not been systematically studied in individuals with TSC and severe autism. The aim of this review is to identify the clinical features of severe autism in TSC, applicable preclinical models, and potential barriers that may warrant strategic planning in the design phase of clinical trial development. A comprehensive search strategy was formed and searched across PubMed, Embase and SCOPUS from their inception to 2/21/12, 3/16/12, and 3/12/12 respectively. After the final search date, relevant, updated articles were selected from PubMed abstracts generated electronically and emailed daily from PubMed. The references of selected articles were searched, and relevant articles were selected. A search of was completed using the search term "TSC" and "tuberous sclerosis complex". Autism has been reported in as many as 60% of individuals with TSC; however, review of the literature revealed few data to support clear classification of the severity of autism in TSC. Variability was identified in the diagnostic approach, assessment of cognition, and functional outcome among the reviewed studies and case reports. Objective outcome measures were not used in many early studies; however, diffusion tensor imaging of white matter, neurophysiologic variability in infantile spasms, and cortical tuber subcategories were examined in recent studies and may be useful for objective classification of TSC in future studies. Mechanism-based treatments for TSC are currently available. However, this literature review revealed two potential barriers to successful design and implementation of clinical trials in individuals with severe autism-an unclear definition of the population and lack of validated outcome measures. Recent studies of objective outcome measures in TSC and further study of applicable preclinical models present an opportunity to overcome these barriers.
    08/2013; 2(3):16-25. DOI:10.5409/wjcp.v2.i3.16
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Treatment Early signs Genetics Pharmacotherapy Neurobiology a b s t r a c t On April 2013 experts in the field of autism from Italy and Israel convened in Jerusalem to discuss and finalize clinical recommendations for early diagnosis and intervention in Autism Spectrum Disorders (ASDs). In this paper, we summarize the results of this Italian eIsraeli consensus conference. ASDs constitute a class of severe and heterogeneous neurodevelopmental conditions caused by atypical brain development beginning during early prenatal life, reflecting many genetic, neurobiological and environmental influences. The first clinical signs of ASDs begin to be evident in children between 12 and 18 months of age, often after a period of relatively typical postnatal development. Recent longitudinal studies reveal substantial diversity in developmental trajectories through childhood and adolescence. Some intervention approaches have been demonstrated to be effective in improving core symptoms of ASDs, even if the heterogeneity and developmental nature of the disorder make it implausible that only one specific treatment will be best for all chil-dren with ASDs. More randomized control trials (RCTs) on early intervention are needed to identify the most effective strategies and provide the most efficient allocation of resources during the critical early intervention time period. Future research should focus on linking biological phenotypes with specific genotypes, thus establishing a foundation for the development of diagnostic screening tools and individualization of treatments. ยช 2013 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society. (P. Curatolo). c Participants listed in the Appendix. Official Journal of the European Paediatric Neurology Society e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y x x x (2 0 1 3) 1 e1 2
    European journal of paediatric neurology: EJPN: official journal of the European Paediatric Neurology Society 09/2013; · 2.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Behavioral interventions are the major source of change for children with autism spectrum disorders and a major cost to families and government. In the last 5 years, a number of carefully designed intervention studies have provided new information about the effects of caregiver training and direct instruction on behavior treatments. Outcomes of these interventions are neither easily assessed nor simple, but are dependent on child characteristics as well as caregiver skills and attitudes. Some interventions aimed at specific skills have similar results, yet there is growing evidence that child interventions may have different effects than caregiver training, although both may affect outcomes in the long term. New research strategies and findings are discussed, with a focus on how underlying behaviors and specific components may contribute to intervention outcomes.
    Annals of the New York Academy of Sciences 11/2013; 1304(1):70-6. DOI:10.1111/nyas.12311 · 4.38 Impact Factor
Show more